As announced late last week, Neovasc, Inc. (NASDAQ: NVCN), a specialty medical device company, made multiple presentations today at the annual Transcatheter Cardiovascular Therapeutics (TCT) symposium in Washington, D.C., the world’s largest educational meeting specializing in interventional cardiovascular medicine. Dr. Anson Cheung, professor of surgery and director of cardiac transplant at St. Paul’s Hospital in Vancouver, Canada, offered an update on the clinical development of the Tiara™ for the transcatheter treatment of mitral valve disease. Meanwhile, Dr. Gregg Stone highlighted the clinical results of the Neovasc Reducer™ for the treatment of refractory angina. This year’s TCT symposium kicked off on October 29 and is scheduled to run through November 2.
To view the full press release, visit: http://nnw.fm/8ZKcb
About Neovasc, Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products in development include the Tiara™, for the transcatheter treatment of mitral valve disease and the Neovasc Reducer™ for the treatment of refractory angina. The Company also sells a line of advanced biological tissue products that are used as key components in third-party medical products including transcatheter heart valves. For more information, visit: www.neovasc.com.
About NetworkNewsBreak
NetworkNewsBreak is a rapid summary of a press release that caught the attention of NetworkNewsWire (NNW). NNW provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing network of more than 5,000 key distribution outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge. For more information, visit https://www.networknewswire.com.
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.net
